Webinar: Medication or Hazardous Waste? New EPA Requirements for Managing Unused Pharmaceuticals
16 April 2019
The EPA’s new hazardous waste pharmaceutical rule takes effect on August 21, 2019. State agencies are scrambling to implement compliant programs in their respective states, creating considerable uncertainty for health care providers, pharmacies, and reverse distributors. Attorneys from Foley’s environmental practice will provide you with a detailed overview of the new requirements and help you prepare by answering:
- How is the new rule different from the current rule and common practices?
- How should you be managing your waste pharmaceuticals today?
- What should you do if the applicable state program is not ready by August 21, 2019?
Webinar Recording
If you have questions or would like more information, please contact Jason Swaby at jswaby@foley.com.
People
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…